Shanghai Yizhong Pharmaceutical Co (SHSE:688091) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 30, 2026)


SHSE:688091 Shanghai Yizhong Pharmaceutical Co Ltd SHSE:688091
60 GF Score
Price ¥40.20
GF Value ¥49.38
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shanghai Yizhong Pharmaceutical Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Shanghai Yizhong Pharmaceutical Co's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SHSE:688091 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Yizhong Pharmaceutical Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Yizhong Pharmaceutical Co Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Yizhong Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Shanghai Yizhong Pharmaceutical Co's Margin of Safety % (DCF Earnings Based) falls into.


SHSE:688091
60GF Score
Shanghai Yizhong Pharmaceutical Co Ltd SHSE:688091
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Yizhong Pharmaceutical Co (SHSE:688091) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Yizhong Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥40.20 is trading 18.6% below its estimated GF Value™ of ¥49.38. GuruFocus considers Shanghai Yizhong Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:688091:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ¥49.38 vs. price of ¥40.20 (18.6% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688091 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Yizhong Pharmaceutical Co Business Description

Address 79 Renqi Road, Fengxian District, Shanghai, CHN, 201403
Shanghai Yizhong Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating research and development, production and sales. It is committed towards the development of new dosage forms of anti-tumor drugs and related products.
60GF Score

Get the complete analysis for SHSE:688091

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥40.20
Price
¥49.38
GF Value